Clinical trials
Obesity, Morbid trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
170 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 9 |
| 2012 | 11 |
| 2013 | 9 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 8 |
| 2017 | 11 |
| 2018 | 12 |
| 2019 | 12 |
| 2020 | 22 |
| 2021 | 13 |
| 2022 | 15 |
| 2023 | 9 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 170 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mansoura University | 7 |
| Fatih Sultan Mehmet Training and Research Hospital | 4 |
| Ain Shams University | 3 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Hadassah Medical Organization | 3 |
| Istanbul University | 3 |
| University of Roma La Sapienza | 3 |
| Catholic University of the Sacred Heart | 2 |
| Federico II University | 2 |
| HaEmek Medical Center, Israel | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity, Morbid | 170 |
| Obesity | 36 |
| Weight Loss | 12 |
| Insulin Resistance | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Metabolic Syndrome | 5 |
| Inflammation | 4 |
| Non-alcoholic Fatty Liver Disease | 4 |
| Postoperative Complications | 4 |
| Diabetes Mellitus | 3 |
Trials
Showing 76 to 100 of 170. Each trial links to its page on Pharma Observatory.
70 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.